slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 69,901-69,930
Pages 3,679
Rows per page 30
Component
69,901-69,930 of 110,355
07
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
14
Standard corporate earnings presentation closing slide.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
01
AbCellera | Investor Presentation Deck | 20 slidesAbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations 1 hit
14
Slide 14 of a pitch deck, includes a list of partner logos.AbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations 1 hit
13
The slide highlights a new undisclosed molecule in Phase 1.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations 1 hit
15
The slide uses a waterfall-style annotation to show the absolute dollar increase between the two periods.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations 1 hit
17
The chart illustrates the bridge between two balance sheet dates using cash flow categories.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations 1 hit
06
Includes a visual representation of debt maturity and a callout regarding interest rate hedging.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
04
The slide uses a Gantt-style chart to represent clinical trial progress.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
06
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
07
Includes testimonials from KOLs to emphasize the difficulty of patient compliance.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
08
The slide uses a pie chart to segment patients and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a biological process diagram showing intracellular vs plasma metabolism.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
11
The chart displays efficacy data for a drug candidate (pegtarviliase) across different dosage cohorts.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution Approach1 hit
15
The slide uses a timeline-based progression of symptoms to illustrate the severity of the disease.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a two-column layout to contrast commercial/regulatory status with clinical trial outcomes.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
17
Includes box plots for arginine levels and bar charts for patient normalization rates.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
18
Clinical trial data presentation with statistical significance markers and MCID thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
23
The slide presents a standard quarterly financial comparison (P&L summary) and balance sheet highlights.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Before After1 hit
26
The slide uses a Kaplan-Meier survival curve and a comparative table to illustrate the severity of the disease.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
27
The slide includes experimental design details and statistical significance markers (p < 0.05).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
32
The chart is a box-and-whisker plot showing longitudinal data from baseline through 56 weeks.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
33
Includes both continuous mean change data and categorical responder analysis.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
The slide includes a disclaimer regarding the exclusion of the TOM FORD FASHION business from the targets.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Impact and Next StepsLoop · Golden Circle1 hit
26
Includes footnote references (1) through (8) and a reference to explanatory notes on slides 32-33.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
27
Includes footnotes referencing slides 32-33 for further explanation.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
28
The slide provides a bridge from IFRS Profit/(Loss) to Adjusted Profit/(Loss) with specific line-item adjustments.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
30
Includes footnotes explaining the nature of specific financial line items.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit